As an attempt to find bioactive medicinal herbs exerting anti-asthmatic activity, the effects of an ethanol extract from the parts of Saururus chinensis were evaluated in both in vitro and in vivo. The ethanol extract of S. chinensis (ESC) inhibited generation of the cyclooxygenase-2 (COX-2) dependent phases of prostaglandin D 2 in bone marrow-derived mast cells in a concentration-dependent manner with an IC 50 value of 14.3 m mg/ml. ESC also inhibited leukotriene C 4 production with an IC 50 value of 0.3 m mg/ml. This demonstrates that ESC has COX-2/5-lipoxygenase dual inhibitory activity. In addition, this compound inhibited degranulation reaction in a dose dependent manner, with an IC 50 value of 1.3 m mg/ml. An ovalbumin induced mouse asthmatic animal model was used to determine its in vivo anti-asthmatic activity. The oral administration (50-200 mg/kg) of ESC reduced the number of infiltrated eosinophil in a bronchoalveolar lavage fluid. Furthermore, ESC (100 mg/kg) inhibited the eotaxin and IL-4 mRNA expression levels. These results suggest that the anti-asthmatic activity of S. chinensis might in part occur via the inhibition of eicosanoid generation, degranulation as well as the down regulation of IL-4 and eotaxin mRNA expression.
Saururus chinensis (Saururaceae) is a perennial herb distributed in China and southern Korea and the aerial part of S. chinensis has been used for folk medicine for the treatment of edema, jaundice, gonorrhea, and several inflammatory diseases in Korea. 1) Previous phytochemical studies of the genus Saururus have demonstrated the presence of more than 20 lignans 2) as well as flavonoids, anthraquinones, and furanoditerpens. 3, 4) Neolignan derivatives isolated from this plant, which are tetrahydrofuran type, are known to have a variety of biological activities such as inhibition of cell adhesion, 5) anti-inflammatory, 6, 7) murine neuroleptic, 8) hepatoprotective 8) and hypercholesterolemia activities. 9) Asthma is an inflammatory disease of the airways, and the current focus in managing asthma is the control of inflammation. In bronchial asthma, various factors result in infiltration of mast cells, eosionphils and T H 2 lymphocytes into the lesions with downstream mediators, leading to the formation of asthmatic phenotypes such as mucous hyperproduction, airway hyper-responsiveness (AHR), and submucosal thickness. 10) A bronchoalveolar lavage (BAL) from allergic asthma consistently showed a higher number of eosinophils, mast cells, and mast cell-derived mediators than the BAL from normal, nonallergic subjects. 11, 12) When activated, many of the effector cells, including the mast cells in asthma, produced a variety of cytokines [13] [14] [15] and newly synthesized eicosanoids. Eicosanoids, which include prostaglandins (PGs) and leukotrienes (LTs) are inflammatory mediators that are biosynthesized in many cell types by cyclooxygenases (COX) and lipoxygenases (LOX) and are strongly associated with inflammatory disorders, acute as well as chronic inflammation. The inhibition of eicosanoid production is one of the important therapeutic strategies in various inflammatory diseases. Among the eicosanoid generating enzymes, an inducible isoform of COX-2 was found to be essential for the production of prostanoids in inflammatory sites. 16) Arachidonic acid can also be converted to LTs via the action of 5-LOX. LTs have biological properties that would be expected for molecules that participate in the pathogenesis of bronchial asthma, and there is evidence for their formation in the airways of asthmatic individuals. 17) Therefore, the dual inhibition of COX-2/5-LOX is believed to be the ideal treatment for allergic diseases and asthma. 18) Although many biological activities of S. chinensis have been reported, the anti-asthmatic activity of S. chinensis has not been reported to date. As part of an ongoing investigation of new biologically active compounds from medicinal herb, the present study was designed to determine the mechanism underlying the anti-asthmatic effect of S. chinensis.
MATERIALS AND METHODS

Materials
The aerial parts of S. chinensis were collected at College of Pharmacy Yeungnam University (Herbal Garden) and identified by professor Ki-Hwan Bae (College of Pharmacy, Chungnam National University, Daejeon, Korea). A voucher specimen has been deposited at the herbarium of the College of Pharmacy, Yeungnam University (YNU 6024). The dried aerial parts of S. chinensis (1 kg) were cut into small pieces and extracted repeatedly with 70% ethanol (EtOH, 2 l). The solution was filtered through filter paper and evaporated in vacuo to give a powered extract (100.3 g). c-kit ligand (KL) and interleukin (IL)-10 were obtained by their expression in baculovirus, as described previously. 19, 20) Lipopolysaccharide (LPS) was from Difco Lab. (Detroit, MI, U.S.A.). Rabbit antisera to mouse COX-1 and COX-2 were purchased from Cayman Chemical (Ann Arbor, MI, U.S.A. BALB/c mice were cultured for up to 10 weeks in 50% enriched medium (RPMI 1640 containing 2 mM L-glutamine, 0.1 mM nonessential amino acids, antibiotics and 10% fetal calf serum) and 50% WEHI-3 cell conditioned medium as a source of IL-3. After 3 weeks Ͼ98% of the cells were found to be BMMC when checked by the previously described procedure.
20)
Determination of PGD 2 To measure the inhibitory activity on COX-2 by an ethanol extract of S. chinensis (ESC), cells suspended at a cell density of 5ϫ10 5 cells/ml in enriched medium were preincubated with aspirin (10 mg/ml) for 2 h to irreversibly inactivate preexisting COX-1. After washing, BMMC were activated with KL (100 ng/ml), IL-10 (100 U/ml) and LPS (100 ng/ml) at 37°C for 8 h in the presence or absence of ESC previously dissolved in dimethylsulfoxide (DMSO). All reactions were stopped by centrifugation at 120ϫg at 4°C for 5 min. The supernatant and cell pellets were immediately frozen in liquid N 2 and stored at Ϫ80°C for further analysis. Under the conditions employed, COX-2-dependent phases of PGD 2 generation reached 1.6 ng/10 6 cells without ESC.
Effect of ESC on 5-LOX Activity BMMC suspended in enriched medium at cell density of 1ϫ10 6 cells/ml were pretreated with ESC for 15 min at 37°C and stimulated with KL (KL; 100 ng/ml). After 20 min of stimulation, the supernatants were isolated for further analysis by EIA. LTC 4 was determined using an enzyme immunoassay kit (Cayman Chemical) according to manufacturer's instruction. Under the conditions employed, the amount of LTC 4 without ESC was reached approximately 500 pg/10 6 cells. Assay of b-hexosaminidase (HEX) release b-HEX, a marker of mast cell degranulation, was quantitated by spectrophotometric analysis of the hydrolysis of p-nitrophenyl-2-acetamido-2-deoxy-b-D-glucopyranoside (Sigma). Briefly, after harvesting supernatant, cells were lysed in the same volume of medium by freeze and thaw three times. Ten microliters of the BMMC lysate or supernatant samples were mixed with 50 ml of b-HEX substrate solution (1.3 mg/ml pnitrophenyl-2-acetamido-2-deoxy-b-D-glucopyranoside in 100 mM sodium citrate, pH 4.5) in each well of 96-well plates and then incubated at 37°C for 60 min. The reaction was stopped by adding 140 ml of 0.2 M Glycin-NaOH (pH 10.7). The absorbance at 410 nm was measured in a microplate reader. The percentage of b-HEX released into the supernatant was calculated by the following formula: [S/(SϩP)]ϫ100, where S and P are the b-HEX contents of supernatant and cell pellet, respectively.
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Total RNA from mouse lung was extracted with TRI ZOL ® reagent (Invitrogen, Carlsbad, CA, U.S.A.) according to the manufacturer's instructions and quantified by measuring optical density at 260 nm and then detected by applying to 1.2% formaldehyde-agarose gels. RT-PCR was carried out using RNA PCR kit (Takara, Shiga, Japan) by thermal cycler (GeneAmp PCR system 2400, Perkin-Elmer, Norwalk, CT, U.S.A.). One microgram of total RNA from each sample was used as template for reverse transcription reaction using 2.5 pmol oligo (dT) 20 primers and 5 units of avian myeloblastosis virus (AMV) reverse transcriptase in 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 5 mM MgCl 2 , 1 unit/ml RNase inhibitor and 1 mM dNTP mixture. The reaction was performed for 10 min at 30°C, 30 min at 42°C, heated to 99°C for 5 min and chilled to 4°C on ice. Two microliters of RT product was used for PCR. PCR was carried out in a final volume of 20 ml containing 1 mM MgCl 2 , 1X PCR buffer, 1 mM dNTP mixture, 1 Unit Taq DNA polymerase (Takara), 0.2 mM each primer. Amplifications were carried out using a thermal cycler with the following profile: 5 min at 94°C before the first cycle, 30 s for denaturation at 94°C, 30 s for primer annealing, 30 s for extension at 72°C, and 5 min at 72°C after the last cycle. Primer sequences and PCR product sizes were as follows: eotaxin, 5Ј-CCA AGG ACT TGG CTT CAT GTA G-3Ј and 5Ј-ATT CTG GCT TGG CAT GGT AGC-3Ј, 495 bp, 25 cycles; IL-4, 5Ј-ACG GCA CAG AGC TAT TGA TG-3Ј and 5Ј-ATG GTG GCT CAG TAC TAC GA-3Ј, 454 bp, 35 cycles. The PCR products were analyzed by 1.2% agarose gel electrophoresis with ethidium bromide staining and UV irradiation. Actin-specific primers (5Ј-CAC CCG CCA CCA GTT CGC CA-3Ј and 5Ј-CAG GTC CCG GCC AGC CAG GT-3Ј, 574 bp, 25 cycles) were used as the positive comparative controls.
Protocol for Allergen Sensitization/Challenge and ESC Treatment Six weeks old female BALB/c were sensitized by intraperitoneal (i.p) administration on days 0, 7, and 14 with 100 mg of OVA in PBS mixed with equal volumes of alum (1 mg) as an adjuvant in a total volume of 200 ml. On days 22 and 24, mice were exposed to aerosolized OVA (1% OVA in PBS) or PBS for 1 h. ESC or dexamethasone (Dexa) was treated for 7 times orally at every 12 h from 1 d before the first challenge to 1 h before the second challenge. The challenge and treatment protocol is shown in Fig. 4A .
BAL Procedure and Determination of Eosinophil Number Eighteen hours after the last aerosol challenge, mice were sacrificed. To obtain BAL fluid (BALF), mice were anesthetized, a tracheal cannula was inserted in each mouse via a midcervical incision, and the airway of each mouse was lavaged three times with 1.5 ml of PBS. BALF was immediately centrifuged (2 min, 4°C, 160ϫg). After removing the supernatant, the cells were resuspended in 0.5 ml of PBS. Ten microliters of the BALF was used for total leukocytes with hemocytometer and the remaining samples were cytospined for Diff-Quick staining (Sysmex, Kobe, Japan). The number of eosinophils was determined by counting more than 200 cells in a microscopic field. The eosinophil % was expressed as a percentage of the total leukocytes. The data is represented as an arithmetic meanϮS.D. (nϭ6).
Statistical Analysis All values were represented as an arithmetic meanϮS.D. One-way ANOVA was used to determine the statistical significance.
RESULTS AND DISCUSSION
Murakami et al. reported that BMMC exhibit biphasic PGD 2 biosynthetic responses over time, as well as COX-1-dependent immediate and COX-2-dependent delayed responses. The immediate PGD 2 generation occurring within 2 h is associated with the coupling of COX-1 with the delayed PGD 2 generation, which is observed after several hours of culturing (during 2-10 h). This is associated with the de novo induction and function of COX-2 after stimulation with particular combinations of cytokines and LPS. 21) This cell model also appears to be suitable for examining the effect of 5-LOX inhibitors because the immediate LTC 4 generation elicited by the IgE-dependent or cytokine-initiated stimulus occurs in BMMC via 5-LOX. 22 ) COX-2-dependent PGD 2 generation was inhibited in a dose-dependent manner in the presence of ESC when the BMMC were activated with a combination of cytokines and LPS with an IC 50 value of approximately 14.3 mg/ml (Fig. 1) . Under the conditions employed, COX-2-dependent phases of PGD 2 generation without the pretreatment of ESC reached approximately 1.6 ng/ 10 6 cells. Arachidonic acid can also be converted to LTs by the action of 5-LOX in BMMC and the inhibition of 5-LOX is believed to be the ideal treatment for allergic diseases and asthma. 18) Therefore, the inhibitory activity of ESC on the generation of LTC 4 in the BMMC was examined. Figure 2 shows that the BMMC stimulated with KL for 15 min produced approximately 500 pg/ml LTC 4 , and preincubation of the BMMC with ESC resulted in the dose-dependent suppression of LTC 4 biosynthesis with an IC 50 value of 0.3 mg/ml.
Mast cells are implicated in the pathology and mortality of anaphylaxis and other allergic disorders by virtue of their ability to be activated through Fc e RI bound antigen-specific IgE. Mast cells may also be activated by various cytokines through each cytokine receptor. Activation through any of these receptors leads to release of a number of biologically active molecules, including histamine, serotonin, proteoglycans and neutral proteases. Among these molecules, histamine is one of the most important chemical mediators in the pathologic allergic reaction. 23) When mast cells are activated by various stimuli, the release of histamine bears a close parallel to that of b-HEX, which is one of degranulation marker. Therefore, the inhibitory activity of ESC on the degranulation reaction in the BMMC was examined. As shown in Fig.  3 , ESC caused the dose-dependent inhibition of b-HEX release with an IC 50 value of 1.3 mg/ml. Under the conditions employed, b-HEX was released about 23-27% without the pretreatment of ESC.
In a murine asthma model, not only eosinophilia in BALF and lung but also the AHR were reduced in genetically mast cell-deficient mice. 24, 25) However, the eosinophilia and AHR were restored by adoptive transfer of BMMC, 24, 25) proving mast cells as key effector cells for the pathophysiology of bronchial asthma. On allergen challenge of airways, the mast cells release the newly synthesized mediators. Among those mediators, LTs and PGs whose increased production has been demonstrated in asthma have significant effects on the eosinophil activation and chemotaxis. [26] [27] [28] [29] Because ESC inhibited both PGD 2 and LTC 4 production in BMMC, these results have led us to determine the biological activity of ESC in in vivo animal model. When 50-200 mg/kg of ESC was administered orally to the mice 7 times, the number of eosinophils was weakly reduced in a dose-dependent manner (Fig. 4B) . The number of total leukocytes in the BALF obtained from the PBS-challenged group was 0.88Ϯ0.21ϫ10 5 cells, but relatively few eosinophils were detected in this group. On the other hand, the total number of leukocytes (6.2Ϯ1.5ϫ10 5 ) and eosinophils (3.84Ϯ0.04ϫ10 5 ) in the BALF of the OVA-challenged lung tissues was significantly higher compared with the PBS-challenged group (data not shown). We could speculate from the result that the reduced eosinophil recruitment into the airway may result from the Fig. 1 . Effect of ESC on COX-2 Dependent PGD 2 Generation BMMC were preincubated for 30 min with the indicated concentration of ESC and then stimulated with KL (100 ng/ml), IL-10 (100 U/ml) and LPS (100 ng/ml) at 37°C for 8 h in the presence or absence of ESC. PGD 2 released into the supernatant was quantified by EIA kit. All determinations were triplicate and the 50% inhibitory concentration was obtained by linear regression analysis at 3.1-50 mg of ESC tested. * * pϽ0.01 and * pϽ0.05 were considered significantly different from the control using an one-way ANOVA test. BMMC were pre-incubated for 30 min with the indicated concentrations of ESC and then stimulated with 100 ng/ml of KL for 15 min. LTC 4 released into the supernatant was quantified by EIA kit. All determinations were triplicate and the 50% inhibitory concentration was obtained by linear regression analysis at 0.2-3.2 mg of ESC tested. * * pϽ0.01 and * pϽ0.05 were considered significantly different from the control using an one-way ANOVA test. decreased LTC 4 and PGD 2 production from mast cells by ESC directly or indirectly.
The chemokine termed eotaxin is a potent eosinophil chemotactic factor that plays a central role in eosinophilic airway inflammation in asthma. 30) Clinical and experimental investigations have reported a strong correlation between the presence of CD 4 ϩ T H 2 cells and disease severity, suggesting an integral role for these cells in the pathophysiology of asthma. 31, 32) Among the T H 2 cytokines, high levels of IL-4 and IL-13 were produced at in an asthmatic lung and are believed to be the key regulators of many of hallmark features of disease. [33] [34] [35] The effect of ESC on the mRNA expression level of the eotaxin and T H 2 cytokine such as IL-4 was examined because ESC reduced the number of infiltrated eosinophils in the BALF. As shown in Fig. 5 , Eotaxin and IL-4 mRNA were undetectable in the normal lung tissue and induced in the OVA-challenged mice compared with the PBSchallenged mice. However, pretreatment of OVA-challenged mice with ESC (100 mg/kg) reduced the transcription levels of eotaxin and IL-4. Dexamethasone (5 mg/kg) also inhibited mRNA expression of those genes from the OVA-challenged lung. Fujitani et al. reported that PGD 2 overproduction increased IL-4, IL-5 and eotaxin in BALF of transgenic mice overexpressing human PGD synthase. 36) In addition, deletion of PGD 2 receptor in mice markedly reduced the pulmonary eosinophilia and AHR, which was accompanied by reduced levels of the T H 2 cytokines (IL-4, IL-5, and IL-13). 37) Futhermore, it was shown that LTC 4 could stimulate eotaxin production by IL-13-treated fibroblasts, thereby indirectly inducing eosinophilic inflammation. 38) Overproduction of eicosanoids in the airway asthma may cause an increase in the level of T H 2 cytokines and an eotaxin accompanied by the enhanced accumulation of eosinophils in the lung. Therefore, the reduction of infiltrated eosinophils in the lung by ESC may occur in part via the inhibition of eicosanoid generation, which reduced directly or indirectly the level of eotaxin and T H 2 cytokines such as IL-4 mRNA expression.
This paper is the first to show that S. chinensis has antiasthmatic activity in in vivo animal model. The results from this study provide an additional rationale for using S. chinensis for treating inflammation related disorders. Eighteen hours after the second aerosol challenge, mice were sacrificed and lungs were taken. Total RNA from lungs of mice was subjected to RT-PCR analysis. Orally administrated amount for ESC and dexamethasone (Dexa) was 100 mg/kg and 5 mg/kg, respectively.
